All Biomarkers

    9p21 (CVD Risk)

    Genetic
    Cardiovascular
    genotype

    The 9p21 locus is the strongest common genetic risk region for coronary artery disease, carried in the DNA you are born with. A preventive practice tests it once because risk variants raise cardiovascular risk independently of cholesterol, helping calibrate how aggressively to pursue prevention.

    What It Measures

    Strongest known common genetic risk locus for CAD.

    Optimal vs. Lab Range

    Longevity Optimal
    0 risk alleles

    Target range for optimal health and longevity based on research.

    Standard Lab
    0/1/2 risk alleles

    Population-based reference range from standard labs.

    Why It Matters

    Risk alleles increase coronary artery disease independent of lipids.

    When Low

    When Optimal

    0 → baseline risk.

    When High

    2 → elevated CAD risk; consider CAC scan earlier.

    How to Optimize

    Standard CVD prevention with earlier imaging surveillance.

    Key Interventions & Linked Compounds

    Moderate (6/10)

    Key Interventions

    Aggressive lifestyle
    lipid control
    BP/glucose management.

    Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

    Ordering Notes

    Specimen

    Buccal swab or whole blood (EDTA)

    Patient prep

    No fasting required. Maintain usual diet and medications unless advised.

    Recommended cadence

    Re-test every 3–6 months when actively optimizing; annually for monitoring.

    Reporting unit

    genotype

    Pre-analytic notes

    Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

    Recommended Follow-Up Actions

    1. 1

      Confirm the result is reliable

      Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift 9p21 (CVD Risk).

    2. 2

      Compare against optimal, not just lab range

      Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.

    3. 3

      Pair with related markers

      Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.

    4. 4

      Discuss interventions with a clinician

      Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.

    5. 5

      Re-test on a defined cadence

      If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation